BetterLife Pharma (STU:NPAU) Short-Term Debt : €0.00 Mil (As of Jan. 2024)

View and export this data going back to 2018. Start your Free Trial

What is BetterLife Pharma Short-Term Debt?

BetterLife Pharma's Short-Term Debt for the quarter that ended in Jan. 2024 was €0.00 Mil.

BetterLife Pharma's quarterly Short-Term Debt stayed the same from Jul. 2023 (€0.06 Mil) to Oct. 2023 (€0.06 Mil) but then declined from Oct. 2023 (€0.06 Mil) to Jan. 2024 (€0.00 Mil).

BetterLife Pharma's annual Short-Term Debt declined from Jan. 2022 (€0.20 Mil) to Jan. 2023 (€0.06 Mil) and declined from Jan. 2023 (€0.06 Mil) to Jan. 2024 (€0.00 Mil).

BetterLife Pharma Short-Term Debt Historical Data

The historical data trend for BetterLife Pharma's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma Short-Term Debt Chart

BetterLife Pharma Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Short-Term Debt

Get a 7-Day Free Trial

0.32

0.20

0.06

BetterLife Pharma Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Short-Term Debt	Get a 7-Day Free Trial															0.06	0.05	0.06	0.06	-

BetterLife Pharma Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

BetterLife Pharma Short-Term Debt Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

BetterLife Pharma (STU:NPAU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (STU:NPAU) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

BETRF:USA NPAU:Germany BETR:Canada

Address

1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6

Website

https://www.abetterlifepharma.com

BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

BetterLife Pharma (STU:NPAU) Headlines

No Headlines